Single User License
INR 169825
Site License
INR 339650
Corporate User License
INR 509475

Service Tax Additional

select a format
Price

Single User License
USD 2500
Site License
USD 5000
Corporate User License
USD 7500

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


Macular Edema Global Clinical Trials Review, H1, 2015

Macular Edema Global Clinical Trials Review, H1, 2015


  Request for Sample Report

Executive Summary

Macular Edema Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Macular Edema Global Clinical Trials Review, H1, 2015" provides data on the Macular Edema clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Macular Edema. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Macular Edema. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each

Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons To Buy

Understand the dynamics of a particular indication in a condensed manner

Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

Obtain discontinued trial listing for trials across the globe

Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Macular Edema 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Macular Edema to Ophthalmology Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Macular Edema to Ophthalmology Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Unaccomplished Trials of Macular Edema 25

Subjects Recruited Over a Period of Time 27

Clinical Trials by Sponsor Type 28

Prominent Sponsors 29

Top Companies Participating in Macular Edema Therapeutics Clinical Trials 30

Prominent Drugs 31

Clinical Trial Profiles 32

Clinical Trial Overview of Top Companies 32

Allergan, Inc. 32

Clinical Trial Overview of Allergan, Inc. 32

Novartis AG 35

Clinical Trial Overview of Novartis AG 35

F. Hoffmann-La Roche Ltd. 37

Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 37

Regeneron Pharmaceuticals, Inc. 39

Clinical Trial Overview of Regeneron Pharmaceuticals, Inc. 39

Pfizer Inc. 40

Clinical Trial Overview of Pfizer Inc. 40

Merck & Co., Inc. 41

Clinical Trial Overview of Merck & Co., Inc. 41

Eyetech Pharmaceuticals, Inc. 42

Clinical Trial Overview of Eyetech Pharmaceuticals, Inc. 42

Bayer AG 43

Clinical Trial Overview of Bayer AG 43

Clearside BioMedical, Inc. 44

Clinical Trial Overview of Clearside BioMedical, Inc. 44

Clinical Trial Overview of Top Institutes / Government 45

National Eye Institute 45

Clinical Trial Overview of National Eye Institute 45

Johns Hopkins University 46

Clinical Trial Overview of Johns Hopkins University 46

Shahid Beheshti University of Medical Sciences 47

Clinical Trial Overview of Shahid Beheshti University of Medical Sciences 47

Assistance Publique-Hopitaux de Paris 48

Clinical Trial Overview of Assistance Publique-Hopitaux de Paris 48

Queen's University 49

Clinical Trial Overview of Queen's University 49

Kagoshima University 50

Clinical Trial Overview of Kagoshima University 50

Wills Eye Institute 51

Clinical Trial Overview of Wills Eye Institute 51

Yamagata University Hospital 52

Clinical Trial Overview of Yamagata University Hospital 52

University of California, San Francisco 53

Clinical Trial Overview of University of California, San Francisco 53

Johann Wolfgang Goethe University Hospitals 54

Clinical Trial Overview of Johann Wolfgang Goethe University Hospitals 54

Five Key Clinical Profiles 55

Appendix 109

Abbreviations 109

Definitions 109

Research Methodology 110

Secondary Research 110

About GlobalData 111

Contact Us 111

Disclaimer 111

Source 111

List of Figures

Macular Edema Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Macular Edema Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Macular Edema Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Macular Edema Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10

Macular Edema Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Macular Edema Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Macular Edema Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13

Macular Edema Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14

Proportion of Macular Edema to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 15

Macular Edema Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Macular Edema Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Macular Edema to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 18

Macular Edema Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Macular Edema Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Macular Edema Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21

Macular Edema Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22

Macular Edema Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Macular Edema Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Macular Edema Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27

Macular Edema Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 28

Macular Edema Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29

Macular Edema Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30

Macular Edema Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31

GlobalData Methodology 110

List of Tables

Macular Edema Therapeutics, Global, Clinical Trials by Region, 2015* 7

Macular Edema Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Macular Edema Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Macular Edema Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10

Macular Edema Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Macular Edema Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Macular Edema Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13

Macular Edema Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14

Proportion of Macular Edema to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 15

Macular Edema Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Macular Edema Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Macular Edema to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 18

Macular Edema Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Macular Edema Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Macular Edema Therapeutics, Global, Clinical Trials by Phase, 2015* 21

Macular Edema Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22

Macular Edema Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Macular Edema Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Macular Edema Therapeutics, Global, Withdrawn Clinical Trials, 2015* 25

Macular Edema Therapeutics, Global, Terminated Clinical Trials, 2015* 26

Macular Edema Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27

Macular Edema Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 28

Macular Edema Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29

Macular Edema Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30

Macular Edema Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31

Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan, Inc., 2015* 32

Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 35

Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 37

Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Regeneron Pharmaceuticals, Inc., 2015* 39

Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 40

Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2015* 41

Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Eyetech Pharmaceuticals, Inc., 2015* 42

Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015* 43

Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Clearside BioMedical, Inc., 2015* 44

Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by National Eye Institute, 2015* 45

Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2015* 46

Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Shahid Beheshti University of Medical Sciences, 2015* 47

Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique-Hopitaux de Paris, 2015* 48

Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Queen's University, 2015* 49

Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Kagoshima University, 2015* 50

Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Wills Eye Institute, 2015* 51

Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Yamagata University Hospital, 2015* 52

Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2015* 53

Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Johann Wolfgang Goethe University Hospitals, 2015* 54

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Macular Edema Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Macular Edema, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.


Related Products in vertical
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com